Background and Objectives Infections play a key role in the development of Guillain-Barré
syndrome (GBS) and have been associated with specific clinical features and disease severity…

Objective To study baseline serum neurofilament light chain (sNfL) levels as a prognostic
biomarker in Guillain-Barré syndrome (GBS). Methods We measured NfL in serum (98 samples…

Previous studies have described the clinical, serological and pathological features of patients
with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and antibodies …

Background and Objectives To study the clinical and laboratory features of antineurofascin-155
(NF155)–positive autoimmune nodopathy (AN). Methods Patients with anti-NF155 …

Background and Objectives An important challenge in diagnosing anti–NMDA receptor (NMDAR)
encephalitis (NMDARe) is differentiating it from a first episode of psychosis (FEP) …

The discovery of autoantibodies against nodal and paranodal proteins has proven useful in
clinical practice, has uncovered novel pathophysiological mechanisms, clinical phenotypes, …

AN have emerged as a new diagnostic category pathologically different from acquired
demyelinating neuropathies. Clinically they overlap with GBS and CIDP although they associate …

Background Guillain–Barré syndrome (GBS) is an acute inflammatory neuropathy with a
heterogeneous presentation. Although some evidences support the role of autoantibodies in its …

Background and aims Symptomatic intracranial atherosclerosis (ICAS) is associated with a
high risk of stroke recurrence and occurrence of other vascular events. However, ICAS has …

Background and Objectives To investigate CSF findings in relation to clinical and electrodiagnostic
subtypes, severity, and outcome of Guillain-Barré syndrome (GBS) based on 1,500 …